| An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face (NCT07729579) | Sun Pharmaceutical Industries Limited | 2026-08-04 |
| Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency (NCT07385547) | Sun Pharmaceutical Industries Limited | 2026-02-25 |
| Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus (NCT07282743) | Sun Pharmaceutical Industries Limited | 2026-01-20 |
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis. (NCT06611163) | Sun Pharmaceutical Industries Limited | 2025-03-21 |
| A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients (NCT06425900) | Sun Pharmaceutical Industries Limited | 2024-07-01 |
| A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients (NCT06415279) | Sun Pharmaceutical Industries Limited | 2024-02-14 |
| A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients (NCT06415292) | Sun Pharmaceutical Industries Limited | 2023-11-27 |
| A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne (NCT06336629) | Sun Pharmaceutical Industries Limited | 2023-11-15 |
| A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne (NCT06336603) | Sun Pharmaceutical Industries Limited | 2023-11-15 |
| A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne (NCT06415305) | Sun Pharmaceutical Industries Limited | 2023-09-01 |
| Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. (NCT05422911) | Sun Pharmaceutical Industries Limited | 2022-08-31 |
| Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis (NCT04991116) | Sun Pharmaceutical Industries Limited | 2022-06-30 |
| A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT05022004) | Sun Pharmaceutical Industries Limited | 2021-12-20 |
| To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis (NCT04684485) | Sun Pharmaceutical Industries Limited | 2021-07-30 |
| Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis (NCT03897075) | Sun Pharmaceutical Industries Limited | 2021-05-13 |
| To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis (NCT04566666) | Sun Pharmaceutical Industries Limited | 2021-03-25 |
| Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis (NCT04506463) | Sun Pharmaceutical Industries Limited | 2020-12-22 |
| Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) (NCT04314531) | Sun Pharmaceutical Industries Limited | 2020-07-01 |
| Effect of Cequa™ in Subjects With Dry Eye Disease (NCT04357795) | Sun Pharmaceutical Industries Limited | 2020-06-29 |
| A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis (NCT03997786) | Sun Pharmaceutical Industries Limited | 2020-01-15 |
| Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab (NCT03992729) | Sun Pharmaceutical Industries Limited | 2019-08-29 |
| A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis (NCT03718299) | Sun Pharmaceutical Industries Limited | 2019-07-16 |
| A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension (NCT03927443) | Sun Pharmaceutical Industries Limited | 2019-06-10 |
| Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis (NCT03897088) | Sun Pharmaceutical Industries Limited | 2019-03-29 |
| Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma (NCT04066504) | Sun Pharmaceutical Industries Limited | 2019-03-11 |
| A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited) (NCT03528577) | Sun Pharmaceutical Industries Limited | 2018-09-22 |
| Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects (NCT01543490) | Sun Pharmaceutical Industries Limited | 2018-03-30 |
| Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery (NCT03192137) | Sun Pharmaceutical Industries Limited | 2018-01-30 |
| 2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery (NCT03192150) | Sun Pharmaceutical Industries Limited | 2018-01-03 |
| A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease (NCT01478555) | Sun Pharmaceutical Industries Limited | 2018-01-01 |
| Efficacy and Safety Study of SUNPG1622 (NCT02980705) | Sun Pharmaceutical Industries Limited | 2017-11-06 |